- Home
- IMUX vs ALTS Comparison
IMUX vs ALTS Comparison
Compare IMUX & ALTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- ALTS
- Stock Information
- Founded
- IMUX 2016
- ALTS 1976
- Country
- IMUX United States
- ALTS United States
- Employees
- IMUX N/A
- ALTS N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- ALTS
- Sector
- IMUX Health Care
- ALTS
- Exchange
- IMUX Nasdaq
- ALTS NYSE
- Market Cap
- IMUX 102.2M
- ALTS 72.7M
- IPO Year
- IMUX N/A
- ALTS N/A
- Fundamental
- Price
- IMUX $1.12
- ALTS $4.09
- Analyst Decision
- IMUX Strong Buy
- ALTS
- Analyst Count
- IMUX 6
- ALTS 0
- Target Price
- IMUX $12.67
- ALTS N/A
- AVG Volume (30 Days)
- IMUX 904.4K
- ALTS 197.7K
- Earning Date
- IMUX 05-07-2025
- ALTS 05-02-2025
- Dividend Yield
- IMUX N/A
- ALTS N/A
- EPS Growth
- IMUX N/A
- ALTS N/A
- EPS
- IMUX N/A
- ALTS N/A
- Revenue
- IMUX N/A
- ALTS $7,110,000.00
- Revenue This Year
- IMUX N/A
- ALTS N/A
- Revenue Next Year
- IMUX N/A
- ALTS N/A
- P/E Ratio
- IMUX N/A
- ALTS N/A
- Revenue Growth
- IMUX N/A
- ALTS N/A
- 52 Week Low
- IMUX $0.92
- ALTS $1.29
- 52 Week High
- IMUX $2.11
- ALTS $7.75
- Technical
- Relative Strength Index (RSI)
- IMUX 51.41
- ALTS 33.65
- Support Level
- IMUX $1.06
- ALTS $4.41
- Resistance Level
- IMUX $1.22
- ALTS $4.91
- Average True Range (ATR)
- IMUX 0.09
- ALTS 0.55
- MACD
- IMUX -0.01
- ALTS -0.23
- Stochastic Oscillator
- IMUX 37.50
- ALTS 1.12
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. It is providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment and safe-keeping of digital assets. The company product include ALT 5 Prime is an electronic over-the-counter trading platform and ALT 5 Pay crypto payment processor.